Article
Resistance associated genomic variations for moderate level tigecycline resistance evolution in Acinetobacter baumannii.
World journal of microbiology & biotechnology - 4 Apr 2026
Acharya Kusumita, Biswas Shatarupa, Bhattacharyya Sayani, Ghosh Mallika, Bhattacharya Arijit
Abstract excerpt
Among the last-resort antibiotics, tigecycline is a semisynthetic drug derivative of tetracycline used in medical facilities, resulting in tigecycline-resistant Acinetobacter baumannii (TRAB) strain development. Recent reports suggested the emergence of heteroresistance, intermediate-resistance, and resistance strain development against the tigecycline of A. baumannii isolates, causing treatment failure in...
Topics
- Tigecycline
- Acinetobacter baumannii
- Anti-Bacterial Agents
- Microbial Sensitivity Tests
- Mutation
- Drug Resistance, Bacterial
- Bacterial Proteins
- Whole Genome Sequencing
- Genome, Bacterial
- Biofilms
